References
- PolanczykGVWillcuttEGSalumGAKielingCRohdeLAADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysisInt J Epidemiol201443243444224464188
- American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders5th edArlington, VAAmerican Psychiatric Publishing2013
- BiedermanJFaraoneSVAttention-deficit hyperactivity disorderLancet2005366948123724816023516
- PliszkaSAACAP Work Group on Quality IssuesPractice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry200746789492117581453
- National Institute for Health and Care Excellence [webpage on the Internet]Attention deficit hyperactivity disorder CG722008 Available from: http://www.nice.org.uk/CG72Accessed March 1, 2018
- TaylorEDopfnerMSergeantJEuropean clinical guidelines for hyperkinetic disorder ? first upgradeEur Child Adolesc Psychiatry200413S11730
- CorteseSHoltmannMBanaschewskiTPractitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescentsJ Child Psychol Psychiatry201354322724623294014
- GordonNThe therapeutics of melatonin: a paediatric perspectiveBrain Dev200022421321710838105
- MaurizJLColladoPSVenerosoCReiterRJGonzález-GallegoJA review of the molecular aspects of melatonin’s anti-inflammatory actions: recent insights and new perspectivesJ Pineal Res201354111422725668
- PorfirioMCGomes de AlmeidaJPStornelliMGiovinazzoSPurper-OuakilDMasiGCan melatonin prevent or improve metabolic side effects during antipsychotic treatments?Neuropsychiatr Dis Treat2017132167217428860773
- ComaiSOchoa-SanchezRGobbiGSleep-wake characterization of double MT1/MT2 receptor knockout mice and comparison with MT1 and MT2 receptor knockout miceBehav Brain Res201324323123823333399
- Wirz-JusticeAArmstrongSMMelatonin: nature’s soporific?J Sleep Res1996521371418795816
- van GeijlswijkIMKorziliusHPSmitsMGThe use of exogenous melatonin in delayed sleep phase disorder: a meta-analysisSleep201033121605161421120122
- AppletonREGringrasPMelatonin: helping to mend impaired sleepArch Dis Child201398321621723413423
- HartzIFuruKBratlidTHandalMSkurtveitSHypnotic drug use among 0–17 year olds during 2004–2011: a nationwide prescription database studyScand J Public Health201240870471123108475
- AnandSTongHBesagFMCChanEWCorteseSWongICKSafety, tolerability and efficacy of drugs for treating behavioural insomnia in children with attention-deficit/hyperactivity disorder: a systematic review with methodological quality assessmentPediatr Drugs2017193235250
- MohammadiMRMostafaviSAKeshavarzSAMelatonin effects in methylphenidate treated children with attention deficit hyperactivity disorder: a randomized double blind clinical trialIran J Psychiatry201272879222952551
- KaufmanJBirmaherBBrentDSchedule for affective disorders and schizophrenia for school-age Children-Present and lifetime version (K-SADS-PL): initial reliability and validity dataJ Am Acad Child Adolesc Psychiatry19973679809889204677
- ConnersCKConners’ Rating Scales: Revised Technical Manual Multi-Health Systems Inc edNYNorth Tonawanda1997
- KaufmanJBirmaherBRaoURyanNTest K-SADS-PL – Intervista diagnostica per la valutazione dei disturbi psicopatologici in bambini e adolescentiTrentoErikson2004
- NobileMAlbertiBZuddasAConners’ Rating Scales-Revised-Italian VersionGiuntiOS2007
- GuyWECDEU Assessment Manual for Psychopharmacology, revisedRockville, MDUS Department of Health, Education and Welfare1976
- AyyashHFPreecePMortonRCorteseSMelatonin for sleep disturbance in children with neurodevelopmental disorders: prospective observational naturalistic studyExp Rev Neurother2015156711717
- KirovRBrandSSleep problems and their effect in ADHDExpert Rev Neurother201414328729924491141